1.19
price up icon8.18%   0.09
after-market 시간 외 거래: 1.19
loading
전일 마감가:
$1.10
열려 있는:
$1.15
하루 거래량:
6,395
Relative Volume:
0.17
시가총액:
$31.50M
수익:
-
순이익/손실:
-
주가수익비율:
-3.4186
EPS:
-0.3481
순현금흐름:
-
1주 성능:
-8.46%
1개월 성능:
+27.00%
6개월 성능:
-60.33%
1년 성능:
-23.23%
1일 변동 폭
Value
$1.108
$1.2308
1주일 범위
Value
$1.10
$1.2802
52주 변동 폭
Value
$0.85
$4.40

Akari Therapeutics Plc Adr Stock (AKTX) Company Profile

Name
명칭
Akari Therapeutics Plc Adr
Name
전화
(646) 350-0702
Name
주소
22 BOSTON WHARF ROAD, BOSTON
Name
직원
12
Name
트위터
@AkariTX
Name
다음 수익 날짜
2024-04-29
Name
최신 SEC 제출 서류
Name
AKTX's Discussions on Twitter

AKTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.19 31.50M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 66.76B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Akari Therapeutics Plc Adr Stock (AKTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2019-01-04 업그레이드 B. Riley FBR Neutral → Buy
2018-02-08 개시 B. Riley FBR, Inc. Neutral
2017-09-22 업그레이드 William Blair Mkt Perform → Outperform
2017-05-31 업그레이드 Chardan Capital Markets Sell → Neutral
2017-04-17 재확인 Chardan Capital Markets Sell
2016-07-11 개시 Chardan Capital Markets Sell
모두보기

Akari Therapeutics Plc Adr 주식(AKTX)의 최신 뉴스

pulisher
Mar 20, 2025

Akari Therapeutics names new CEO to drive cancer drug innovation - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Akari Therapeutics names new CEO to drive cancer drug innovation By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Ibotta Inc (IBTA) Shares Soar Above 1-Year High - The News Heater

Mar 20, 2025
pulisher
Mar 20, 2025

Akari Therapeutics Appoints New CEO, Current CEO to Step Down By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Akari Therapeutics Appoints New CEO, Current CEO to Step Down - Investing.com

Mar 20, 2025
pulisher
Mar 03, 2025

Akari Therapeutics secures $7.6 million in private placement - Investing.com India

Mar 03, 2025
pulisher
Feb 03, 2025

Major ADC Developer Akari Opens Direct Channel to Investors Through Webull Platform - StockTitan

Feb 03, 2025
pulisher
Dec 28, 2024

Akari Therapeutics, Plc (NASDAQ:AKTX) Sees Significant Growth in Short Interest - Defense World

Dec 28, 2024
pulisher
Dec 18, 2024

Akari Therapeutics appoints new CEO and board member - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

Akari Therapeutics names Samir Patel as CEO and adds board member - Investing.com India

Dec 18, 2024
pulisher
Dec 18, 2024

Akari Therapeutics Names Interim CEO Patel as Permanent Chief, Adds Jazz Pharma Veteran to Board - StockTitan

Dec 18, 2024
pulisher
Dec 16, 2024

Akari Therapeutics appoints new CFO - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

Akari Therapeutics appoints new CFO By Investing.com - Investing.com South Africa

Dec 16, 2024
pulisher
Dec 16, 2024

AKTXAkari Therapeutics plc ADR (0.01 USD) Latest Stock News & Market Updates - StockTitan

Dec 16, 2024
pulisher
Dec 16, 2024

Akari Therapeutics Strengthens Leadership: Former CFO Returns After $50M Fundraising Success - StockTitan

Dec 16, 2024
pulisher
Nov 19, 2024

Akari Therapeutics Regains Nasdaq Compliance, Secures Market Listing Status | AKTX Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 14, 2024

Akari Therapeutics Announces Successful Completion of Merger of Akari Therapeutics and Peak Bio - Benzinga

Nov 14, 2024
pulisher
Nov 14, 2024

Akari Therapeutics Completes Peak Bio Merger, Secures $53.2M in Financing Commitments | AKTX Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 08, 2024

Akari Therapeutics shareholders approve Peak Bio merger - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Akari Therapeutics shareholders approve Peak Bio merger By Investing.com - Investing.com UK

Nov 08, 2024
pulisher
Nov 08, 2024

Akari Therapeutics Announces Shareholder Approval in Connection With Peak Bio, Inc. Merger - StockTitan

Nov 08, 2024
pulisher
Nov 01, 2024

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN

Nov 01, 2024
pulisher
Oct 15, 2024

Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger - StockTitan

Oct 15, 2024
pulisher
Oct 05, 2024

Akari Therapeutics Plc faces Nasdaq delisting over equity shortfall - Investing.com India

Oct 05, 2024
pulisher
Sep 12, 2024

Akari Therapeutics PlcADR (AKTX) Price Target Increased by 45.45% to 81.60 - MSN

Sep 12, 2024
pulisher
Jun 05, 2024

Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders - StockTitan

Jun 05, 2024
pulisher
Sep 29, 2023

Akari Therapeutics Reports First Half 2023 Financial Results and Highlights - StockTitan

Sep 29, 2023
pulisher
Apr 11, 2023

Akari Therapeutics to Attend ARVO 2023, the Annual Meeting of The Association for Research in Vision and Ophthalmology - StockTitan

Apr 11, 2023
pulisher
Mar 30, 2023

Akari Therapeutics, Plc Announces $4 Million Registered Direct Offering - StockTitan

Mar 30, 2023
pulisher
Nov 04, 2022

Peak Bio (PKBO) Stock Price, News & Analysis - MarketBeat

Nov 04, 2022
pulisher
Jan 20, 2021

The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance

Jan 20, 2021
pulisher
Jul 20, 2019

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.25% - Investing.com Australia

Jul 20, 2019
pulisher
Apr 24, 2017

Dow Jones News: Dow Rallies 200 Points After Macron and Le Pen Win First Round of French Election - Money Morning

Apr 24, 2017
pulisher
Aug 18, 2016

Angion Biomedica (ANGN) Stock Price, News & Analysis - MarketBeat

Aug 18, 2016
pulisher
Jul 27, 2011

ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - ADVFN

Jul 27, 2011

Akari Therapeutics Plc Adr (AKTX) 재무 분석

Akari Therapeutics Plc Adr (AKTX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
자본화:     |  볼륨(24시간):